C4 Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CCCC Nasdaq 2830 www.c4therapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for C4 Therapeutics, Inc.

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice - Aug 21st, 2026 10:00 am
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates - Aug 11th, 2026 6:15 am
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Aug 11th, 2026 5:00 am
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year? - Jul 7th, 2026 7:40 am
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know - Jul 3rd, 2026 10:00 am
C4 Therapeutics (CCCC) Gains Over the Past Month, Can It Go Higher? - Jul 3rd, 2026 7:11 am
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Jun 18th, 2026 7:40 am
C4 Therapeutics Reports 53% Response Rate for Cemsidomide at RP2D - Jun 11th, 2026 5:46 am
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population - Jun 11th, 2026 5:00 am
C4 Therapeutics (CCCC) Upgraded to Buy: What Does It Mean for the Stock? - Jun 1st, 2026 10:00 am
Emerging Hope in Multiple Myeloma Market: 7 Late-Stage Therapies Nearing the Finish Line | DelveInsight - May 25th, 2026 11:00 am
C4 Therapeutics to Participate in Upcoming Conferences - May 20th, 2026 5:00 am
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 18th, 2026 2:01 pm
C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Reported And Analysts Have Been Lifting Their Price Targets - May 15th, 2026 7:15 am
C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates - May 12th, 2026 6:10 am
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights - May 12th, 2026 5:00 am
Assessing Roche Holding (SWX:ROG) Valuation After New C4 Therapeutics Oncology Partnership - Apr 21st, 2026 12:04 am
Roche’s DAC investment; Big Pharma’s lavish CEO bumps - Apr 17th, 2026 2:00 am